Previous close | 10,862.00 |
Open | 10,946.00 |
Bid | 10,996.00 x 0 |
Ask | 10,998.00 x 0 |
Day's range | 10,938.00 - 11,018.00 |
52-week range | 9,461.00 - 12,348.00 |
Volume | |
Avg. volume | 2,909,494 |
Market cap | 170.494B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 35.94 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (2.10%) |
Ex-dividend date | 22 Feb 2024 |
1y target est | N/A |
Facing accusations of greed, the pay packages of FTSE CEOs are back in the headlines. But our writer takes a more relaxed view, on one condition. The post I don’t care how much FTSE bosses are paid as long as they make me rich! appeared first on The Motley Fool UK.
The FDA approves AstraZeneca's (AZN) Fasenra as an add-on maintenance treatment for patients with severe asthma aged six to 11 years.
J&J (JNJ) is set to buy Shockwave Medical (SWAV). FDA approves AstraZeneca's (AZN) Enhertu for metastatic HER2-positive solid tumors.